Department of Neurosurgery, Kantonsspital Aarau; Cerebrovascular Research Group, Department for BioMedical Research, University of Bern;
Department of Neurosurgery, Kantonsspital Aarau; Cerebrovascular Research Group, Department for BioMedical Research, University of Bern.
J Vis Exp. 2022 Mar 16(181). doi: 10.3791/63580.
Microsurgical clipping creates a subsequent barrier of blood flow into intracranial aneurysms, whereas endovascular treatment relies on neointima and thrombus formation. The source of endothelial cells covering the endoluminal layer of the neointima remains unclear. Therefore, the aim of the present study was to investigate the origin of neointima-forming cells after cell-tracer injection in the already well-established Helsinki rat microsurgical sidewall aneurysm model. Sidewall aneurysms were created by suturing decellularized or vital arterial pouches end-to-side to the aorta in male Lewis rats. Before arteriotomy with aneurysm suture, a cell-tracer injection containing CM-Dil dye was performed into the clamped aorta to label endothelial cells in the adjacent vessel and track their proliferation during follow-up (FU). Treatment followed by coiling (n = 16) or stenting (n = 15). At FU (7 days or 21 days), all rats underwent fluorescence angiography, followed by aneurysm harvesting and macroscopic and histological evaluation with immunohistological cell counts for specific regions of interest. None of the 31 aneurysms had ruptured upon follow-up. Four animals died prematurely. Macroscopically residual perfusion was observed in 75.0% coiled and 7.0% of stented rats. The amount of cell-tracer-positive cells was significantly elevated in decellularized stented compared to coiled aneurysms with respect to thrombus on day 7 (p = 0.01) and neointima on day 21 (p = 0.04). No significant differences were found in thrombus or neointima in vital aneurysms. These findings confirm worse healing patterns in coiled compared to stented aneurysms. Neointima formation seems particularly dependent on the parent artery in decellularized aneurysms, whereas it is supported by the recruitment from aneurysm wall cells in vital cell-rich walls. In terms of translation, stent treatment might be more appropriate for highly degenerated aneurysms, whereas coiling alone might be adequate for aneurysms with mostly healthy vessel walls.
显微夹闭术在颅内动脉瘤中形成了后续的血流屏障,而血管内治疗则依赖于新生内膜和血栓形成。新生内膜覆盖的内皮层细胞来源尚不清楚。因此,本研究旨在探讨在已建立的赫尔辛基大鼠显微侧壁动脉瘤模型中,细胞示踪剂注射后新生内膜形成细胞的来源。通过将脱细胞或有活力的动脉囊从一端到另一端缝合到主动脉上来创建侧壁动脉瘤。在进行夹闭动脉的血管切开术之前,将含有 CM-Dil 染料的细胞示踪剂注射到夹闭的主动脉中,以标记相邻血管中的内皮细胞,并在随访期间(FU)追踪其增殖。然后进行 coil(n = 16)或 stent(n = 15)治疗。在 FU(7 天或 21 天)时,所有大鼠均进行荧光血管造影,然后进行动脉瘤收获和宏观及组织学评估,并用免疫组织化学细胞计数对特定感兴趣区域进行计数。在随访期间,没有 31 个动脉瘤破裂。有 4 只动物过早死亡。在 coil 组中,75.0%的动脉瘤和 stent 组中 7.0%的动脉瘤存在残余灌注。与 coil 组相比,在第 7 天(p = 0.01)和第 21 天(p = 0.04),脱细胞 stent组的细胞示踪阳性细胞数量在血栓和新生内膜中均显著增加。在有活力的动脉瘤中,血栓或新生内膜没有显著差异。这些发现证实了 coil 组的愈合模式比 stent 组差。在脱细胞动脉瘤中,新生内膜的形成似乎特别依赖于母动脉,而在富含细胞的有活力的血管壁中,新生内膜的形成则依赖于从动脉瘤壁细胞募集。在翻译方面,支架治疗可能更适合高度退化的动脉瘤,而单纯 coil 治疗可能足以治疗大多数血管壁健康的动脉瘤。